CDRH Gets Specific About RF Cardiac Ablation Indications At RAPS
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to issue a new guidance on general versus specific indications and product labeling, according to CDRH Office of Device Evaluation Director Daniel Schultz
You may also be interested in...
510(k) General Surgery Indication Policy Clarified By ODE Director At RAPS
Sponsors of surgical devices that have been 510(k) cleared for general indications should collect clinical data for specific procedures if they are cited as examples in physician training, ODE posits
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.